31/05/2012 Dr. Montalban in the World Multiple Sclerosis Day 31/05/2012 Dr. Xavier Montalban, head of the clinical neuroimmunology group at Vall d'Hebron Research Institute (VHIR) and director of the Center of Multiple Sclerosis of Catalonia (CEMCAT) was one of the participants in a conference about multiple sclerosis (MS) celebrated on May 30 coinciding with the World Day of this disease.With the sponsorship of the laboratories Biogen Idec, El Mundo, Yo Dona and Diario Médico, the headquarters of Unidad Editorial hosted a meeting with patients, neurologists, researchers and representatives of the industry. Dr. Montalban emphasized that MS is still a critical illness, but "the inflammatory component has better treatments although the degenerative one still is a challenge".Dr. Montalban also took part in a press conference organized by CEMCAT to present the advances in the research of MS. Dr. Xavier Montalban, head of the clinical neuroimmunology group at Vall d'Hebron Research Institute (VHIR) and director of the Center of Multiple Sclerosis of Catalonia (CEMCAT) was one of the participants in a conference about multiple sclerosis (MS) celebrated on May 30 coinciding with the World Day of this disease.With the sponsorship of the laboratories Biogen Idec, El Mundo, Yo Dona and Diario Médico, the headquarters of Unidad Editorial hosted a meeting with patients, neurologists, researchers and representatives of the industry. Dr. Montalban emphasized that MS is still a critical illness, but "the inflammatory component has better treatments although the degenerative one still is a challenge".Dr. Montalban also took part in a press conference organized by CEMCAT to present the advances in the research of MS. Twitter LinkedIn Facebook Whatsapp
